↓ Skip to main content

From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline

Overview of attention for article published in Molecular Neurodegeneration, June 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

news
2 news outlets
twitter
4 X users

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
117 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
From basic research to the clinic: innovative therapies for ALS and FTD in the pipeline
Published in
Molecular Neurodegeneration, June 2020
DOI 10.1186/s13024-020-00373-9
Pubmed ID
Authors

Rajka Maria Liscic, Antonella Alberici, Nigel John Cairns, Maurizio Romano, Emanuele Buratti

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 117 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 117 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 20%
Researcher 14 12%
Student > Bachelor 14 12%
Student > Master 14 12%
Professor 8 7%
Other 15 13%
Unknown 29 25%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 20%
Neuroscience 21 18%
Medicine and Dentistry 14 12%
Agricultural and Biological Sciences 6 5%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 12 10%
Unknown 37 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 August 2023.
All research outputs
#2,298,734
of 24,230,934 outputs
Outputs from Molecular Neurodegeneration
#264
of 904 outputs
Outputs of similar age
#61,258
of 401,233 outputs
Outputs of similar age from Molecular Neurodegeneration
#8
of 13 outputs
Altmetric has tracked 24,230,934 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 904 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.5. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 401,233 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one is in the 46th percentile – i.e., 46% of its contemporaries scored the same or lower than it.